Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4493
+0.0161 (3.72%)
At close: Aug 20, 2026, 4:00 PM EDT
0.4493
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:10 PM EDT
Impact BioMedical Revenue
Impact BioMedical had revenue of $3.00K in the quarter ending June 30, 2026, a decrease of -57.14%. This brings the company's revenue in the last twelve months to $35.00K, up 400.00% year-over-year. In the year 2025, Impact BioMedical had annual revenue of $32.00K.
Revenue (ttm)
$35.00K
Revenue Growth
+400.00%
P/S Ratio
1,382.58
Revenue / Employee
$17,500
Employees
2
Market Cap
48.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 50.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Metagenomi Therapeutics | 13.56M |
| TScan Therapeutics | 7.11M |
| Immutep | 5.28M |
| RenovoRx | 1.98M |
| Hyperion DeFi | 1.40M |
| Mereo BioPharma Group | 500.00K |
| aTyr Pharma | 190.00K |
IBO News
- 13 days ago - Impact BioMedical Quarterly report: Q2 2026 - Filings
- 3 months ago - Impact BioMedical Quarterly report: Q1 2026 - Filings
- 4 months ago - Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans - GlobeNewsWire
- 5 months ago - Impact BioMedical Annual report: Q4 2025 - Filings
- 6 months ago - Why Is Impact BioMedical Stock (IBO) Up Today? - TipRanks
- 10 months ago - Impact BioMedical Quarterly report: Q3 2025 - Filings
- 11 months ago - Impact BioMedical Proxy statement: Proxy Filing - Filings
- 1 year ago - Impact BioMedical announces 3F U.S. patent issue - TheFly